Alto Neuroscience (ANRO) insider buying

Healthcare · Biotechnology · Market cap $860M

3 open-market purchases of ANRO by Alto Neuroscience's executives and directors since February 2024, worth $10M in total, from SEC Form 4 filings.

The most recent: Adam Savitz bought $152,069 on July 9, 2024.

The biggest buyer over the period is Wave Global Lp Alpha: 1 purchase, $10M.

By year

YearPurchasesValue
20243$10M

Biggest buyers

InsiderBuysValue
Wave Global Lp Alpha
1$10M
Adam Savitz
1$152,069
Nicholas Conrad Smith
1$100,614

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Jul 9, 2024 Adam Savitz
12,069$12.60$152,069 Form 4
Mar 28, 2024 Nicholas Conrad Smith
6,150$16.36$100,614 Form 4
Feb 6, 2024 Wave Global Lp Alpha
600,000$16.00$10M Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ANRO.
Open ANRO in Investingly

Questions

Are Alto Neuroscience insiders buying the stock?

3 open-market purchases of ANRO by Alto Neuroscience's executives and directors since February 2024, worth $10M in total, from SEC Form 4 filings. The most recent: Adam Savitz bought $152,069 on July 9, 2024.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Alto Neuroscience's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.